業績一覧

ACHIEVEMENT LIST

  • Hanai N, Shimizu Y, Kariya S, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Sakurai D, Asakage T, Doi I, Yamada T, Homma A:Correction to: Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicentre retrospective clinical study.

    Int J Clin Oncol. 26:1005-1006,2021

  • Okano S, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ogawa T, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Yokota T, Imamura Y, Ariizumi Y, Akimoto T, Hayashi R :Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck.

    Jpn J Clin Oncol. 51:173-179,2021

  • Shiga K, Nibu KI, Fujimoto Y, Asakage T, Homma A, Mitani H, Ogawa T, Okami K, Murono S, Hirano S, Ueda T, Hanai N, Tsukahara K, Ota I, Yoshimoto S, Shinozaki T, Iwae S, Katagiri K, Saito D, Kiyota N, Tahara M, Takahashi F, Hayashi:Multi-institutional Survey of Squamous Cell Carcinoma of the External Auditory Canal in Japan.

    Laryngoscope. 131:E870-E874,2021,2021

  • Taguchi J, Shimizu Y, Ariga S, Goda T, Ohhara Y, Honma R, Noguchi T, Takeuchi S, Kinoshita I, Amano T, Mizumachi T, Kano S, Takahara M, Abe T, Homma A, Dosaka-Akita H:Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.

    Int J Clin Oncol. 26:51-58, 2021

  • Yasuda K, Minatogawa H, Dekura Y, Takao S, Tamura M, Tsushima N, Suzuki T, Kano S, Mizumachi T, Mori T, Nishioka K, Shido M, Katoh N, Taguchi H, Fujima N, Onimaru R, Yokota I, Kobashi K, Shimizu S, Homma A, Shirato H, Aoyama H: Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients.

    J Radiat Res. 62 :329-337, 2021

  • Yokota T, Ota Y, Fujii H, Kodaira T, Shimokawa M, Nakashima T, Monden N, Homma A, Ueda S, Akimoto T:Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2).

    Int J Clin Oncol. 26:316-325,2021

  • Kariya S, Shimizu Y, Hanai N, Yasumatsu R, Yokota T, Fujii T, Tsukahara K, Yoshida M, Hanyu K, Ueda T, Hirakawa H, Takahashi S, Ono T, Sano D, Yamauchi M, Watanabe A, Omori K, Yamazaki T, Monden N, Kudo N, Arai M, Yonekura S, Asakage T, Fujiwara A, Yamada T, Homma A:Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting.

    Int J Clin Oncol. 26:1049-1056,2021

  • Sato K, Ujiie H, Nakazato S, Watanabe M, Watanabe E, Yanagi T, Nakamaru Y, Takagi D, zArai R, Onodera T, Kondo T, Teshima T, Shimizu H:Rosai-Dorfman disease: earlier spontaneous regression of skin lesions relative to nasal, pharyngeal, and bone lesions.

    Eur J Dermatol. 30: 182-183, 2021

  • Hyodo M, Hisa Y, Nishizawa N, Omori K, Shiromoto O, Yumoto E, Sanuki T, Nagao A, Hirose K, Kobayashi T, Asano K, Sakaguchi M.:The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan.

    Auris Nausus Larynx. 48:179-184, 2021